Cargando…
Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
Evidence of the advantages of Coptidis Rhizoma (CR) for the treatment of ulcerative colitis (UC) is accumulating. However, research revealing the targets and molecular mechanisms of CR against UC is scarce. In this research, a bioinformatics analysis was performed to carry out the physicochemical pr...
Autores principales: | Yang, Yuanming, Hua, Yiwei, Chen, Weihuan, Zheng, Huan, Wu, Haomeng, Qin, Shumin, Huang, Shaogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748441/ https://www.ncbi.nlm.nih.gov/pubmed/36532769 http://dx.doi.org/10.3389/fphar.2022.1037856 |
Ejemplares similares
-
Shenling Baizhu Powder Alleviates TNBS-Induced Colitis in Rats by Improving Intestinal Epithelial Permeability and Inhibiting Inflammation Through the TLR5/MyD88/NF-κB Pathway
por: Rao, Kehan, et al.
Publicado: (2022) -
Rhizoma Coptidis: A Potential Cardiovascular Protective Agent
por: Tan, Hui-Li, et al.
Publicado: (2016) -
Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
por: He, Luying, et al.
Publicado: (2022) -
Molecular Targets and Mechanisms of Scutellariae radix-Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking
por: Niu, Kai, et al.
Publicado: (2021) -
Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022)